ReCoTA Reconfigurable Colloids For Therapeutic Applications
- Coordinator
- Universitat Politecnica De Valencia, Spain
- Runs
- 1 March 2027 to 28 February 2031
- Status
- Running
- EU funding
- €4.6m
- Total cost
- —
- Partners
- 20 organisations in 9 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101312142
What the project is doing
In the project's own words, from its summary on CORDIS.
ReCoTA aims to establish an interdisciplinary training network on the emerging topic of smart colloidal materials for therapeutic applications. Over the past decades, major efforts have advanced the development of colloids (i.e., micro and nanoparticles) for drug delivery. Yet, while these systems have demonstrated improved pharmacokinetics, they mainly act as passive, individually operating carriers that release their payload by simple diffusion or unspecific matrix degradation.
There is a clear need for strategies that achieve selective therapeutic action at the target site. ReCoTA will take the next step by designing colloids via molecular and nanomaterials engineering, to obtain programmable assemblies capable of reading environmental cues and translating them into localized therapeutic delivery. The consortium includes top-tier academics (including several ERC AdG/CoG/StG/EIC grantees) and 9 companies with synergistic expertise in the areas of materials engineering, synthetic chemistry, drug development and manufacturing scale-up. 15 Doctoral Candidates (DCs) will be trained in molecular building-block design, fabrication/functionalization of micro-/nano-assemblies, and rigorous biological evaluation.
The training program – covering scientific and non-academic aspects – will prepare DCs for careers across academia and industry. Altogether, ReCoTA will install European leadership in next-generation colloids aligned with health-innovation priorities.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitat Politecnica De Valencia | Valencia | Spain | Coordinator |
| Eidgenoessische Technische Hochschule Zuerich | Zuerich | Switzerland | Participant |
| Johannes Gutenberg-Universitat Mainz | Mainz | Germany | Participant |
| Lignilabs GmbH | Mainz | Germany | Associatedpartner |
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Participant |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe | Valencia | Spain | Participant |
| Nanomol Technologies SL | Cerdanyola Del Valles | Spain | Participant |
| Universitat Autonoma De Barcelona | Cerdanyola Del Valles | Spain | Associatedpartner |
| Aalto Korkeakoulusaatio Sr | Espoo | Finland | Participant |
| Flim Labs SRL | Roma | Italy | Associatedpartner |
| Nanophoenix SRL | Trieste | Italy | Associatedpartner |
| Sphera Encapsulation SRL | Villafranca Di Verona Dossobuono | Italy | Associatedpartner |
| Universita Degli Studi Di Trieste | Trieste | Italy | Participant |
| Dsm Food Specialties BV | Delft | Netherlands | Associatedpartner |
| Nanoworx B.v. | Eindhoven | Netherlands | Participant |
| Technische Universiteit Eindhoven | Eindhoven | Netherlands | Participant |
| Frinkle AB | Skärblacka | Sweden | Associatedpartner |
| SPARTA Biodiscovery Limited | London | United Kingdom | Associatedpartner |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI